Corvus Pharmaceuticals Inc (CRVS)
EBITDA
-$17.22M
Quarterly · Period ending: · USD
CRVS EBITDA
Latest reported-$17.22Mperiod ending
Latest reported-$17.22Mperiod ending
CRVS Quarterly EBITDA ($153.64K → -$17.22M)
Quarterly EBITDA
High-resolution chart · PNG
CRVS ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -17,216,000 | |
| -11,879,000 | |
| -12,295,000 | |
| -10,129,000 | |
| -7,969,000 | |
| 15,215,000 | |
| -12,093,000 | |
| -40,196,000 | |
| -4,241,000 | |
| -5,678,000 | |
| -6,625,000 | |
| -5,970,000 | |
| -6,467,000 | |
| -7,816,000 | |
| -9,722,000 | |
| -14,737,000 | |
| -8,271,000 | |
| -8,210,000 | |
| -9,135,000 | |
| -10,554,000 | |
| -11,630,000 | |
| -11,346,000 | |
| -9,737,000 | |
| -9,698,000 | |
| -10,608,000 | |
| -13,085,000 | |
| -11,255,000 | |
| -11,327,000 | |
| -13,410,000 | |
| -12,119,000 | |
| -10,991,000 | |
| -10,921,000 | |
| -12,038,000 | |
| -14,425,000 | |
| -11,970,000 | |
| -12,733,000 | |
| -14,966,000 | |
| -16,013,000 | |
| -11,065,000 | |
| -10,317,000 | |
| -8,681,000 | |
| -6,320,000 | |
| 11,553,000 | |
| -3,065,000 | |
| -2,297,000 | |
| -2,213,000 | |
| 153,636 |